(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for ...
Read more
(Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a ...
Read more
Dawn Demet had never even heard the word metastatic.Then in September 2011, she was diagnosed with Stage IV metastatic breast cancer. She was told to go home, pack a bag, ...
Read more
New drugs spurred along by research at Pfizer Inc. laboratories in Groton couldn't provide enough lift to make up for losses in the company's established portfolio as the firm announced ...
Read more
In its second wind as a company, Esperion Therapeutics (once owned by Pfizer) has just collected $33 million to continue with clinical trials of its cholesterol-lowering drug.Plymouth, Michigan-based Esperion is ...
Read more
(Reuters) - Drugmakers Pfizer Inc and Merck & Co Inc said they would jointly develop Pfizer's experimental type 2 diabetes drug, ertugliflozin, and expect late-stage trials to start later in ...
Read more
CHAZY -- Local investors will purchase the former Pfizer research facility in the Town of Chazy.Empire State Development and Clinton County announced Monday that Clinton Industrial Development Acquisition LLC had ...
Read more
(Reuters) - Health regulators have granted a "breakthrough therapy" designation to an experimental Pfizer Inc treatment for breast cancer, lifting the company's shares and putting a spotlight on its growing ...
Read more
April 3, 2013 10:17 pm by Brown, Nick | 0 Comments
(Reuters) - A federal appeals court said Pfizer Inc should pay about $142 million to cover costs for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a ...
Read more
(Reuters) - Pfizer Inc has failed to persuade a federal judge to dismiss a shareholder lawsuit accusing the company of fraudulently misrepresenting the cardiovascular risks associated with its Bextra and ...
Read more
LONDON (Reuters) - Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was turned down for use on ...
Read more
(Reuters) - The Food and Drug Administration has added Pfizer Inc's tuberculosis treatment rifampin to its list of drugs in short supply, the latest in a growing number of spottily ...
Read more
(Reuters) - The Food and Drug Administration on Tuesday said that the antibiotic azithromycin, sold as Zithromax or Zmax, can cause a potentially fatal irregular heart rhythm in some patients.Earlier ...
Read more
February 17, 2013 4:37 am by Howard, Lee | 0 Comments
For a man like John LaMattina who lived and breathed science, stepping into the daytime television environment of "The Dr. Oz Show" was a bit like Daniel entering the lion's ...
Read more
February 11, 2013 4:23 am by Howard, Lee | 0 Comments
Pfizer Inc. has quietly cut hundreds of jobs at its Groton laboratories over the past year, leaving a workforce that is slightly smaller than what the pharmaceutical giant projected as ...
Read more
